Prasterone

CHEMBL90593 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
288.4 g/mol
LogP
3.2
Phase
4

Prasterone (dehydroepiandrosterone, DHEA) is an endogenous steroid hormone and neurosteroid precursor that is peripherally converted to androgens and estrogens in target tissues, and also acts as a GABA receptor antagonist and NMDA receptor agonist. It is approved for the treatment of moderate-to-severe dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women, and is under investigation for various other conditions.

분자량

288.4000 g/mol

LogP

3.20

TPSA

37.30 Ų

리핀스키 5의 법칙

통과

치료 영역

작용 기전

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

기전

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

InChI

InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1

Molecular Formula

C19H28O2

HBD / HBA

1 / 2

회전 가능 결합

0

무거운 원자

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Prasterone (dehydroepiandrosterone, DHEA) is an endogenous steroid hormone and neurosteroid precursor that is peripherally converted to androgens and estrogens in target tissues, and also acts as a GABA receptor antagonist and NMDA receptor agonist. It is approved for the treatment of moderate-to-severe dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women, and is under investigation for various other conditions.

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

Yes, Prasterone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL90593. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5881. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.